Cargando…
Therapeutic Drug Monitoring of Amikacin in Neutropenic Oncology Patients
Amikacin is the antibiotic of choice for the treatment of Gram-negative infections, namely, those in neutropenic oncology patients. No populational pharmacokinetic studies are currently available reporting amikacin pharmacokinetics in neutropenic oncology patients despite their specific pathophysiol...
Autores principales: | Aquino, Maria, Tinoco, Maria, Bicker, Joana, Falcão, Amílcar, Rocha, Marília, Fortuna, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952017/ https://www.ncbi.nlm.nih.gov/pubmed/36830283 http://dx.doi.org/10.3390/antibiotics12020373 |
Ejemplares similares
-
Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
por: Silva, Soraia, et al.
Publicado: (2021) -
Therapeutic drug monitoring of amikacin in septic patients
por: Duszynska, Wieslawa, et al.
Publicado: (2013) -
Pharmacokinetic Monitoring of Levetiracetam in Portuguese Refractory Epileptic Patients: Effect of Gender, Weight and Concomitant Therapy
por: Silva, Rui, et al.
Publicado: (2020) -
Pharmacodynamics of nine generic products of amikacin compared with the innovator in the neutropenic mouse thigh infection model
por: Zuluaga, Andres F., et al.
Publicado: (2015) -
Clinical Application of Pharmacokinetics to Appraise Adherence to Levetiracetam in Portuguese Epileptic Patients
por: Silva, Rui, et al.
Publicado: (2022)